Medication Treatments

Study of Extended-Release Buprenorphine Yields Diverse Benefits
A longer duration of treatment with the injectable formulation of buprenorphine for opioid use disorder was associated with more favorable abstinence outcomes in a newly published study.
ASAM: Access to Medication for OUD Must Not Be Impeded
A major update to the American Society of Addiction Medicine's practice guideline for treating opioid use disorder includes the advice that unavailability or refusal of psychosocial treatment should not impede patient access to medication.
Three Steps to Overcoming Obstacles to MAT
Overcoming stigma and cultivating a strong care team are among the components identified in Altarum's discussions with providers on addressing barriers to medication treatment for opioid use disorder.
OUD Medication Patients Had Heightened Risk of Overdose Post-Treatment
An analysis of a state's publicly funded treatment for opioid use disorder found a substantially lower overdose death risk for patients receiving medication treatment, with risk for all patients increasing post-treatment.
Initiative Targets Opioid Treatment, HIV Care in Hard-Hit Regions
A new initiative will seek to identify rapid-cycle improvements to treatment for patients with opioid use disorder and at risk of HIV.
Elevate Spotlight: Best Practices in Opioid Addiction Treatment
With the far reach of the opioid epidemic and the high comorbidity of opioid addiction with other psychiatric disorders, the session will be relevant to all attendees, not just those in addiction medicine.
NCAD West: Prescription Opioid Misuse Drops, but Providers Need to Stay Vocal
During the opening plenary of NCAD West on Thursday, Colorado Consortium for Prescription Drug Abuse director Rober Valuck, PhD, RPh, FNAP, implored attendees to aggressively fight barriers to treatment, scrutinize their own work, and learn from their peers.
NCAD West: Focus on Function When Treating Chronic Pain
Las Vegas Recovery Center chief medical officer Mel Pohl, MD, DFASAM, shared risks of using opioids to treat chronic pain and offered non-medication alternatives to improve patients’ ability to function on Thursday at NCAD West.
Lofexidine Demonstrates Efficacy During Early Opioid Withdrawal
SAN DIEGO—The opioid withdrawal drug lofexidine demonstrated statistically significant efficacy across a half-dozen patient- and clinician-reported outcomes during the first 7 days after immediate opioid cessation, according to study presented at…
Robust Treatment Options Remain Limited for Stimulant Use Disorder
SAN DIEGO—Prescribers who may be seeing an increase in patients with stimulant use disorders are still left relying on off-label treatment options with limited evidence of effectiveness, a researcher told a Psych Congress audience.
Managing Patients With Opioid Use Disorder and Chronic Pain
SAN DIEGO—Mental health clinicians will likely be taking on many more patients with opioid use disorder, as 40% of primary care providers will not accept any new patients who take opioids, an expert said at Psych Congress 2019.
Back to Top